Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BEAT
stocks logo

BEAT

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-0.155
-13.89%
--
--
-0.140
-22.22%
--
--
-0.150
-0%
Estimates Revision
The market is revising No Change the revenue expectations for HeartBeam, Inc. (BEAT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -46.67%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.79%
In Past 3 Month
Stock Price
Go Down
down Image
-46.67%
In Past 3 Month
Wall Street analysts forecast BEAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BEAT is 6.00 USD with a low forecast of 4.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast BEAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BEAT is 6.00 USD with a low forecast of 4.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.720
sliders
Low
4.00
Averages
6.00
High
8.00
Current: 0.720
sliders
Low
4.00
Averages
6.00
High
8.00
Roth Capital
NULL -> Buy
initiated
$4
2025-10-31
Reason
Roth Capital
Price Target
$4
2025-10-31
initiated
NULL -> Buy
Reason
Roth Capital initiated coverage of HeartBeam with a Buy rating and $4 price target. The company is developing a credit-card-sized, cable-free cardiac device that synthesizes a 12-lead electrocardiogram, the analyst tells investors in a research note. The firm expects FDA clearance in the "coming days" that will initially focus on advanced cardiac arrhythmias within the concierge medicine market.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Heartbeam Inc (BEAT.O) is -1.20, compared to its 5-year average forward P/E of -2.78. For a more detailed relative valuation and DCF analysis to assess Heartbeam Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.78
Current PE
-1.20
Overvalued PE
-1.44
Undervalued PE
-4.11

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.09
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.33
Undervalued EV/EBITDA
-0.50

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
87.39
Current PS
0.00
Overvalued PS
374.59
Undervalued PS
-199.80
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

BEAT News & Events

Events Timeline

(ET)
2025-11-26
16:37:09
HeartBeam Revises Regulatory Approach for 12-Lead ECG Synthesis Software
select
2025-11-21 (ET)
2025-11-21
12:35:36
Roth anticipates possible FDA approval for HeartBeam despite correspondence received
select
2025-11-21
12:32:23
HeartBeam Declines Following FDA's 'Not Substantially Equivalent' Letter
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.5
11-29Benzinga
Crude Oil Rises by 1%; Tilray Brands Stock Drops Sharply

  • U.S. Stock Market Performance: U.S. stocks rose on Friday, with the Dow Jones increasing by over 250 points, while the NASDAQ and S&P 500 also saw gains. Energy shares led the rise, up 1.6%, while health care stocks fell by 0.6%.

  • Notable Stock Movements: Chagee Holdings Limited's shares rose by 7% after earnings release, while DeFi Technologies Inc. surged 11% following the approval of a compliant CAD stablecoin. Pasithea Therapeutics Corp. saw a 61% increase after announcing a public offering.

  • Declines in Specific Stocks: Rubico Inc. and Tilray Brands, Inc. experienced significant drops of 25% and 19%, respectively, due to reverse stock splits. Rich Sparkle Holdings Limited fell 34% after announcing a partnership involving EDU tokens.

  • Commodity and International Market Updates: Oil and gold prices increased, with silver and copper also seeing gains. European shares were generally higher, while Asian markets closed mixed, with Japan's Nikkei slightly up and Hong Kong's Hang Seng down.

[object Object]
Preview
4.5
11-28Benzinga
Nasdaq Increases by 100 Points; Chagee Stock Surges Following Q3 Earnings Report

  • U.S. Stock Market Performance: U.S. stocks opened higher, with the Nasdaq Composite gaining approximately 100 points, while the Dow, S&P 500, and communication services sectors also saw increases.

  • Earnings Reports: Chagee Holdings Limited's shares rose 4% after reporting a decline in net income and revenues for Q3, while other companies like SMX and Pasithea Therapeutics experienced significant stock price surges following positive announcements.

  • Market Movements: Several stocks, including Rubico Inc. and Tilray Brands, faced declines due to reverse stock splits, while commodities like oil and gold saw slight increases.

  • Global Market Overview: European shares were mostly up, with mixed results in Asian markets, as Japan's Nikkei gained slightly while Hong Kong's Hang Seng fell. No major economic reports were scheduled for release.

[object Object]
Preview
2.0
11-28Benzinga
Heartbeam Shares Surge Approximately 43%; Check Out 20 Stocks Making Moves in Premarket Trading

  • Heartbeam Inc's Stock Surge: Heartbeam Inc's shares rose 43.3% in pre-market trading after announcing its regulatory strategy following the FDA's Not Substantially Equivalent decision on its Electrocardiogram Synthesis Software, with plans for an appeal or 510(k) resubmission.

  • Other Notable Gainers: Several stocks saw significant gains in pre-market trading, including SMX PLC (+73.1%), Zenta Group (+26.7%), and Waton Financial (+21.1%), reflecting a positive trend in the market.

  • Major Losers: FBS Global Ltd experienced a sharp decline of 24.3%, while Tilray Brands fell 15% after announcing a reverse stock split, indicating volatility among certain stocks.

  • Market Overview: The pre-market trading session showed mixed results, with notable gains for some companies and significant losses for others, highlighting the fluctuating nature of the stock market.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Heartbeam Inc (BEAT) stock price today?

The current price of BEAT is 0.72 USD — it has increased 2.27 % in the last trading day.

arrow icon

What is Heartbeam Inc (BEAT)'s business?

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

arrow icon

What is the price predicton of BEAT Stock?

Wall Street analysts forecast BEAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BEAT is 6.00 USD with a low forecast of 4.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Heartbeam Inc (BEAT)'s revenue for the last quarter?

Heartbeam Inc revenue for the last quarter amounts to -5.29M USD, increased 4.36 % YoY.

arrow icon

What is Heartbeam Inc (BEAT)'s earnings per share (EPS) for the last quarter?

Heartbeam Inc. EPS for the last quarter amounts to -3242000.00 USD, decreased -4.90 % YoY.

arrow icon

What changes have occurred in the market's expectations for Heartbeam Inc (BEAT)'s fundamentals?

The market is revising No Change the revenue expectations for HeartBeam, Inc. (BEAT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -46.67%.
arrow icon

How many employees does Heartbeam Inc (BEAT). have?

Heartbeam Inc (BEAT) has 21 emplpoyees as of December 05 2025.

arrow icon

What is Heartbeam Inc (BEAT) market cap?

Today BEAT has the market capitalization of 24.61M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free